Supa Hannongbua
Overview
Explore the profile of Supa Hannongbua including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Meelua W, Wanjai T, Thinkumrob N, Olah J, Mujika J, Ketudat-Cairns J, et al.
J Biomol Struct Dyn
. 2021 Mar;
40(16):7439-7449.
PMID: 33715601
The endo-1,5-α-L-arabinanases, belonging to glycoside hydrolase family 43 (GH43), catalyse the hydrolysis of α-1,5-arabinofuranosidic bonds in arabinose-containing polysaccharides. These enzymes are proposed targets for industrial and medical applications. Here, molecular...
32.
Ratanabunyong S, Aeksiri N, Yanaka S, Yagi-Utsumi M, Kato K, Choowongkomon K, et al.
Chembiochem
. 2020 Oct;
22(5):915-923.
PMID: 33095511
HIV-1 RT is a necessary enzyme for retroviral replication, which is the main target for antiviral therapy against AIDS. Effective anti-HIV-1 RT drugs are divided into two groups; nucleoside inhibitors...
33.
Seetaha S, Hannongbua S, Rattanasrisomporn J, Choowongkomon K
Chem Biol Drug Des
. 2020 Aug;
97(1):157-166.
PMID: 32757477
The HIV-1 reverse transcriptase (HIV-1 RT), which is responsible for transcription of viral RNA genomes into DNA genomes, has become an important target for the treatment of patients with HIV...
34.
Kamsri P, Hanwarinroj C, Phusi N, Pornprom T, Chayajarus K, Punkvang A, et al.
J Chem Inf Model
. 2019 Dec;
60(1):226-234.
PMID: 31820972
The enoyl-acyl carrier protein reductase InhA of is an attractive, validated target for antituberculosis drug development. Moreover, direct inhibitors of InhA remain effective against InhA variants with mutations associated with...
35.
Jitapunkul K, Poachanukoon O, Hannongbua S, Toochinda P, Lawtrakul L
Cell Mol Bioeng
. 2019 Nov;
11(1):77-89.
PMID: 31719880
Introduction: Compound D and DMPBD are compounds extracted from Plai or Roxb., which have antiasthmatic properties. Thai herbal pharmacopoeia have indicated that approximate 50% of Thai prescriptions for asthma contain...
36.
Prajongtat P, Sriprachuabwong C, Wongkanya R, Dechtrirat D, Sudchanham J, Srisamran N, et al.
ACS Appl Mater Interfaces
. 2019 Jul;
11(31):27677-27685.
PMID: 31305061
Fully printable perovskite solar cells (PPSCs) attract attention in the photovoltaic industry and research owing to their controllable and scalable production with reduced material waste during manufacturing. However, the commercialization...
37.
Punkvang A, Kamsri P, Mulholland A, Spencer J, Hannongbua S, Pungpo P
J Chem Inf Model
. 2019 Mar;
59(4):1422-1433.
PMID: 30840825
Shikimate dehydrogenase (SDH) from Mycobacterium tuberculosis ( MtbSDH), encoded by the aroE gene, is essential for viability of M. tuberculosis but absent from humans. Therefore, it is a potentially promising...
38.
Paracha T, Pobsuk N, Salaloy N, Suphakun P, Pekthong D, Hannongbua S, et al.
Molecules
. 2019 Jan;
24(2).
PMID: 30646523
Pulmonary arterial hypertension (PAH) is a rare and progressive disease arising from various etiologies and pathogenesis. PAH decreases life expectancy due to pulmonary vascular remodeling, elevation of mean pulmonary arterial...
39.
Pobsuk N, Suphakun P, Hannongbua S, Nantasenamat C, Choowongkomon K, Gleeson M
Med Chem
. 2018 Dec;
15(6):693-704.
PMID: 30569870
Background: Despite the development of extensive control strategies and treatment options, approximately 200 million malaria cases, leading to approximately 450,000 deaths, were reported in 2015. Due to issue of disease...
40.
Pobsuk N, Paracha T, Chaichamnong N, Salaloy N, Suphakun P, Hannongbua S, et al.
Bioorg Med Chem Lett
. 2018 Dec;
29(2):267-270.
PMID: 30509781
We describe the design, synthesis and evaluation of a series of N,N-diaminoquinazoline analogs as PDE5 inhibitors. Twenty compounds were prepared and these were assessed in terms of their PDE5 and...